Real-Time Evaluation of the Effects of Dexamethasone on Osteoblasts Using Dual Labeling with Fluorescent Probes

Abstract:

Similar to other glucocorticoids, dexamethasone (DEX) induces osteoblast differentiation. At high concentrations, glucocorticoids may induce osteoporosis as a side effect. However, the exact mechanism of these two opposing effects has not been elucidated. To understand the mechanism of DEX-induced osteoblast differentiation, we developed a real-time osteoblast differentiation detection system using dual labeling of cells with fluorescent proteins. The promoter sequences of type I collagen and osteocalcin were ligated with mCherry and green fluorescent protein (GFP), respectively. Type I collagen is an early marker of osteoblast differentiation, and osteocalcin is a terminal differentiation marker. We investigated the effects of DEX on cell proliferation and differentiation using cells transformed with both constructs. Low DEX concentrations (<10 μM) induced calcification, as determined by alizarin-red staining, whereas calcification was inhibited at higher concentrations (>100 μM). Consistent with these results, mCherry-associated red fluorescence as an early marker was evident under both conditions, whereas green fluorescence associated with terminal differentiation was evident only at lower DEX concentrations. The level of green fluorescence diminished in a DEX-concentration-dependent manner. Thus, DEX does not inhibit the early stages of osteoblast differentiation but instead inhibits terminal differentiation.

• Periodical: Key Engineering Materials (Volume 631)
• Pages: 379-383
• DOI: https://doi.org/10.4028/www.scientific.net/KEM.631.379
• Online since: November 2014
• Authors: Hitomi Ohsugi, Junichi Hatsukawa, Masahiro Takahara, Mamoru Aizawa, Nobuyuki Kanzawa*
• Keywords: Dexamethasone, Differentiation Makers, Fluorescent Proteins, Osteoblast, Promoter

References

[1] L. Zou, Y. Luo, M. Chen, G. Wang, M. Ding, C.C. Petersen, et al, A simple method for deriving functional MSCs and applied for osteogenesis in 3D scaffolds, Sci Rep 3 (2013) open article #2243.

[2] E. Canalis, Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis, J. Clin. Endocrinol. Metab. 81 (1996) 3441–3447.

DOI: 10.1210/jc.81.10.3441

[3] M.S. Cooper, M. Hewison, P.M. Stewart, Glucocorticoid activity, inactivity and the osteoblast, J. Endocrinol. 163 (1999) 159-164.

DOI: 10.1677/joe.0.1630159

[4] I. Fujita, J. Hirano, N. Itoh, T. Nakanishi, K. Tanaka, Dexamethasone induces sodium-dependent vitamin C transporter in a mouse osteoblastic cell line MC3T3-E1, Br. J. Nutr. 86 (2001) 145-149.

DOI: 10.1079/bjn2001406

[5] C.C. Chua, B.H.L. Chua, Z. Chen, C. Landy, R.C. Hamdy, Dexamethasone induces caspase activation in murine osteoblastic MC3T3-E1 cells, Biochim. Biophys. Acta 1642 (2003) 79–85.

DOI: 10.1016/s0167-4889(03)00100-9

[6] I. Kalajzic, Z. Kalajzic, M. Kaliterna, G. Gronowicz, S.H. Clark, C. Lichtler, et al., Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage, J. Bone Miner. Res. 17 (2002).

DOI: 10.1359/jbmr.2002.17.1.15

[7] C. Desbois, D. Hogue, G. Karsenty, The mouse osteocalcin gene cluster contains three genes with two separate spatial and temporal patterns of expression, J. Biol. Chem. 269 (1994) 1183–1190.

DOI: 10.1016/s0021-9258(17)42240-x

[8] Y. Qin, Z. Zhang, L. Yu, J. He, Y. Hou, T. Liu, et al. A20 overexpression under control of mouse osteocalcin promoter in MC3T3-E1 cells inhibited tumor necrosis factor-alpha-induced apoptosis, Acta Pharmacol. Sin. 27(2006) 1231–1237.

DOI: 10.1111/j.1745-7254.2006.00403.x

[9] D. Hong, H. Chen, H. Yu, C. Wang, H.T. Deng, Q.Q. Lian, et al., Quantitative proteomic analysis of dexamethasone-induced effects on osteoblast differentiation, proliferation, and apoptosis in MC3T3-E1 cells using SILAC, Osteoporos. Int. 22 (2011).

DOI: 10.1007/s00198-010-1434-8